260
Participants
Start Date
September 27, 2023
Primary Completion Date
November 26, 2029
Study Completion Date
December 26, 2029
[203Pb]VMT-α-NET
\[203Pb\]VMT-α-NET is administered by intravenous bolus injection for single-photon emission computed tomography imaging.
[212Pb]VMT-α-NET
\[212Pb\]VMT-α-NET is administered by intravenous infusion for treatment of SSTR2 expressing neuroendocrine tumors.
RECRUITING
Johns Hopkins, Baltimore
RECRUITING
Virginia Cancer Specialists, Fairfax
RECRUITING
Mayo Clinic, Jacksonville
RECRUITING
Biogenix Molecular, Miami
RECRUITING
Vanderbilt-Ingram Cancer Center, Nashville
RECRUITING
University of Kentucky, Lexington
RECRUITING
Ohio State University, Columbus
RECRUITING
Michigan Health Professionals, Troy
RECRUITING
Barbara Ann Karmanos Cancer Institute, Detroit
RECRUITING
BAMF Health, Grand Rapids
RECRUITING
University of Iowa, Iowa City
RECRUITING
Mayo Clinic, Rochester
RECRUITING
The University of Chicago, Chicago
RECRUITING
Washington University, St Louis
RECRUITING
Nebraska Cancer Specialists, Omaha
Lead Sponsor
Perspective Therapeutics
INDUSTRY